Closed petition Ensure UK cancer patients retain access to the latest treatments after Brexit
The European Commission has made it clear it would see a post-Brexit UK as falling outside EU regulations on clinical trials and the licensing of new medications.
This could cause significant delay, or even prevent, cancer patients receiving essential life extending medications following a no-deal.
The Government should ensure that cancer patients in the UK retain access to clinical trials taking place across the EU and to any newly approved treatments.
This petition closed early because of a General Election Find out more on the Petitions Committee website
Government will respond
Government responds to all petitions that get more than 10,000 signatures
Waiting for a new Petitions Committee after the General Election